Stealth Liposomes Encapsulating Zoledronic Acid: A New Opportunity To Treat Neuropathic Pain-Reference-Cited by-同舟云学术

Stealth Liposomes Encapsulating Zoledronic Acid: A New Opportunity To Treat Neuropathic Pain

Published:2013-02-14 Issue:3 Volume:10 Page:1111-1118
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Caraglia Michele,Luongo Livio,Salzano Giuseppina¹,Zappavigna Silvia,Marra Monica,Guida Francesca¹,Lusa Sara¹,Giordano Catia,De Novellis Vito,Rossi Francesco,Abbruzzese Saccardi Alberto,De Rosa Giuseppe¹,Maione Sabatino

Affiliation:

1. Department of Pharmacy, University Federico II of Naples, Via Montesano, 49, 80131 Naples, Italy

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/mp3006215

Reference43 articles.

1. Neuropathic Pain: A Maladaptive Response of the Nervous System to Damage

2. Central sensitization and LTP: do pain and memory share similar mechanisms?

3. Cellular and Molecular Mechanisms of Pain

4. Central neuron–glial and glial–glial interactions following axon injury

5. Resting Microglial Cells Are Highly Dynamic Surveillants of Brain Parenchyma in Vivo

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A cutting-edge new framework for the pain management in children: nanotechnology;Frontiers in Molecular Neuroscience;2024-09-10

2. THERAPEUTIC IMPACT OF NANOMEDICINE FOR THE TREATMENT OF NEUROPATHIC PAIN: PRINCIPLE, PROSPECTIVE AND FUTURE;International Journal of Applied Pharmaceutics;2024-09-07

3. AN UPDATED REVIEW OF STEALTH LIPOSOMES AND ITS ABILITY TO EVADE THE IMMUNE SYSTEM: A NEW FRONTIER IN CANCER CHEMOTHERAPY;International Journal of Applied Pharmaceutics;2024-05-07

4. Sulfur quantum dots for fluorescence sensing in biological and pharmaceutical samples: a review;Materials Advances;2024

5. Liposomes as a Potential Carrier for Brain Delivery;Application of Nanocarriers in Brain Delivery of Therapeutics;2024